异源组合指数:验证冠状动脉疾病预测生物标志物
Kenan Toprak1, Mustafa Kaplangöray2, Mesut Karataş3
1Harran University, Faculty of Medicine, Department of Cardiology, Sanliurfa, Turkey.
Archives of medical research
|August 4, 2024
概括
这种新的动脉性综合指数 (ACI) 有效地预测了冠状动脉疾病 (CAD) 的存在和严重程度. 这种脂质生物标志物为评估CAD风险和进展提供了一个有前途的工具.
科学领域:
- 心血管医学 心血管医学
- 脂质学 脂质学是指脂质学.
- 生物标志物发现发现
背景情况:
- 动脉动脉原体和抗动脉原体脂质颗粒的不平衡与冠状动脉疾病 (CAD) 的发展和严重程度有关.
- 动脉样硬化进展受到脂质颗粒失调的影响,影响CAD风险.
- 目前的生物标志物可能无法完全捕捉到累积的无机效应.
研究的目的:
- 引入和验证异原组合指数 (ACI) 作为一种新的脂质生物标志物.
- 评估ACI的综合能力,以反映异构和抗异构颗粒的平衡.
- 确定ACI与CAD的存在和严重程度的关联.
主要方法:
- 横截面研究包括1,830名CAD患者和650名非CAD对照.
- 患者根据SYNTAX得分 (SS) 分类为分组.
- 对ACI和其他指数进行比较,以预测CAD的存在和严重程度.
主要成果:
- 与非CAD组相比,CAD组的ACI水平显著更高 (p < 0.05).
- ACI显示出与SYNTAX得分的强有力的线性关联 (r = 0.527; p < 0.001).
- 多变量分析证实ACI是CAD存在 (OR: 1.602) 和严重程度 (OR: 1.296) 的独立预测因子.
结论:
- 甲基综合指数 (ACI) 显示了作为CAD的强大生物标志物的潜力.
- ACI可以更好地预测冠状动脉疾病的存在和严重程度.
- 这一新型索引提供了对CAD相关的脂质颗粒平衡的全面评估.
更多相关视频
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
387
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
956
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
121
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
121
